Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,831,207
+$19,118,475 QoQ
Shares Held
334,382
+347.7% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. BBIO ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in BBIO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,831,207 | 334,382 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,712,732 | 74,686 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $5,258,509 | 101,242 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $18,252,832 | 422,715 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $14,583,664 | 421,859 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $22,719,167 | 827,958 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $21,214,188 | 833,236 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $781,405 | 30,849 | Shares | Other | 2024-08-14 | |
| 2023-12-31 | $1,529,901 | 37,897 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $4,296,094 | 162,916 | Shares | Other | 2023-11-14 | |
| 2023-03-31 | $17,982,584 | 1,084,595 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $708,175 | 71,245 | Shares | Other | 2022-11-14 | |
| 2021-12-31 | $4,843,238 | 290,362 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $727,375 | 15,519 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $4,681,292 | 75,995 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||